
Official Patient Website | ERLEADA® (apalutamide)
ERLEADA ® is a prescription medicine used to treat two types of prostate cancer: Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or …
About Prostate Cancer | ERLEADA® (apalutamide)
This is called metastatic castration-sensitive prostate cancer, or mCSPC. The most common sites where prostate cancer can spread are bones, liver, and lungs. View the ERLEADA® Patient …
About ERLEADA® | ERLEADA® (apalutamide)
ERLEADA ® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: that has spread to other parts of the body and still responds to a medical or surgical treatment …
YOU NEVER THOUGHT YOU’D SEE THE DAY. BEING THERE IS POSSIBLETM WHAT IS ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of …
Prostate cancer treatment is personal. Use this tool to help guide an open conversation about your patients’ goals and preferences, and help support a decision to add ERLEADA® to their …
When it comes to prostate cancer treatment, it helps to understand your type of prostate cancer and how ERLEADA® can help. If your doctor has prescribed ERLEADA®, it’s because you …
Starting ERLEADA® | ERLEADA® (apalutamide)
Learn about starting treatment with ERLEADA®, including tips for talking to your doctor, how to receive your prescription, and more. See full Prescribing & Safety Info.
Official Patient Website | ERLEADA® (apalutamide)
ERLEADA ® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: that has spread to other parts of the body and still responds to a medical or surgical treatment …
Sitemap | ERLEADA® (apalutamide)
Before taking ERLEADA®, tell your healthcare provider about all your medical conditions, including if you: have a history of heart disease have high blood pressure have diabetes have …
YOU NEVER THOUGHT YOU’D SEE THE DAY. BEING THERE IS POSSIBLETM WHAT IS ERLEADA®? ERLEADA® (apalutamide) is a prescription medicine used for the treatment of …